Risk of Hip/Femur Fracture After Stroke A Population-Based Case-Control Study

被引:135
|
作者
Pouwels, Sander [1 ]
Lalmohamed, Arief [1 ]
Leufkens, Bert [1 ]
de Boer, Anthonius [1 ]
Cooper, Cyrus [2 ,3 ]
van Staa, Tjeerd [1 ,2 ]
de Vries, Frank [1 ,2 ]
机构
[1] Univ Utrecht, Div Pharmacoepidemiol & Pharmacotherapy, Utrecht Inst Pharmaceut Sci, NL-3508 TB Utrecht, Netherlands
[2] Univ Southampton, Southampton Gen Hosp, MRC Epidemiol Resource Ctr, Southampton, Hants, England
[3] Univ Oxford, Inst Musculoskeletal Sci, Oxford, England
关键词
bone density; fracture; risk factors; stroke; BONE-MINERAL DENSITY; OSTEOPOROSIS; EPIDEMIOLOGY; FALLS; HOSPITALIZATION; MEN;
D O I
10.1161/STROKEAHA.109.554055
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Background and Purpose-Stroke increases the risk of hip/femur fracture, as seen in several studies, although the time course of this increased risk remains unclear. Therefore, our purpose is to evaluate this risk and investigate the time course of any elevated risk. Methods-We conducted a case-control study using the Dutch PHARMO Record Linkage System database. Cases (n = 6763) were patients with a first hip/femur fracture; controls were matched by age, sex, and region. Odds ratio (OR) for the risk of hip/femur fracture was derived using conditional logistic regression analysis, adjusted for disease and drug history. Results-An increased risk of hip/femur fracture was observed in patients who experienced a stroke at any time before the index date (adjusted OR, 1.96; 95% CI, 1.65-2.33). The fracture risk was highest among patients who sustained a stroke within 3 months before the index date (adjusted OR, 3.35; 95% CI, 1.87-5.97) and among female patients (adjusted OR, 2.12; 95% CI, 1.73-2.59). The risk further increased among patients younger than 71 years (adjusted OR, 5.12; 95% CI, 3.00-8.75). Patients who had experienced a hemorrhagic stroke tended to be at a higher hip/femur fracture risk compared with those who had experienced an ischemic stroke. Conclusions-Stroke is associated with a 2.0-fold increase in the risk of hip/femur fracture. The risk was highest among patients younger than 71 years, females, and those whose stroke was more recent. Fall prevention programs, bone mineral density measurements, and use of bisphosphonates may be necessary to reduce the occurrence of hip/femur fractures during and after stroke rehabilitation. (Stroke. 2009;40:3281-3285.)
引用
收藏
页码:3281 / 3285
页数:5
相关论文
共 50 条
  • [1] Risk of hip fracture after stroke: A population-based case-control study
    Pouwels, S.
    Lalmohamed, A.
    Thio, B.
    Leufkens, H. G. M.
    Cooper, C.
    van Staa, T.
    de Vries, F.
    BONE, 2009, 44 (02) : S416 - S417
  • [2] Dopaminergic drugs and the risk of hip or femur fracture: a population-based case-control study
    Arbouw, M. E. L.
    Movig, K. L. L.
    van Staa, T. P.
    Egberts, A. C. G.
    Souverein, P. C.
    de Vries, F.
    OSTEOPOROSIS INTERNATIONAL, 2011, 22 (07) : 2197 - 2204
  • [3] Antipsychotic use and the risk of hip/femur fracture: a population-based case-control study
    Pouwels, S.
    van Staa, T. P.
    Egberts, A. C. G.
    Leufkens, H. G. M.
    Cooper, C.
    de Vries, F.
    OSTEOPOROSIS INTERNATIONAL, 2009, 20 (09) : 1499 - 1506
  • [4] (YOUNG INVESTIGATOR AWARD) RISK OF HIP FRACTURE AFTER STROKE: A POPULATION-BASED CASE-CONTROL STUDY
    Pouwels, S.
    Lalmohamed, A.
    Thio, B. M. K. S.
    Ozer, K.
    Leufkens, H. G. M.
    Cooper, C.
    van Staa, T. P.
    de Vries, F.
    OSTEOPOROSIS INTERNATIONAL, 2009, 20 : S263 - S264
  • [5] Use of Dopaminergic Drugs and Risk of Hip or Femur Fracture: A Population-Based Case-Control Study
    Arbouw, Maurits
    Movig, Kris
    van Staa, Tjeerd
    Egberts, Toine
    Souverein, Patrick
    de Vries, Frank
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2009, 18 : S201 - S202
  • [6] Use of proton pump inhibitors and risk of hip/femur fracture: a population-based case-control study
    S. Pouwels
    A. Lalmohamed
    P. Souverein
    C. Cooper
    B. J. Veldt
    H. G. Leufkens
    A. de Boer
    T. van Staa
    F. de Vries
    Osteoporosis International, 2011, 22 : 903 - 910
  • [7] Inhaled corticosteroids and risk of hip/femur fracture: Disease or drugs? A population-based Case-Control study
    de Vries, Frank
    Pouwels, Sander
    Bracke, Madelon
    Lammers, Janwillem
    Leufkens, Bert
    Zuidgeest, Mira
    van Staa, Tjeerd
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2006, 15 : S269 - S269
  • [8] Use of proton pump inhibitors and risk of hip/femur fracture: a population-based case-control study
    Pouwels, S.
    Lalmohamed, A.
    Souverein, P.
    Cooper, C.
    Veldt, B. J.
    Leufkens, H. G.
    de Boer, A.
    van Staa, T.
    de Vries, F.
    OSTEOPOROSIS INTERNATIONAL, 2011, 22 (03) : 903 - 910
  • [9] Antipsychotic use and the risk of hip/femur fracture: a population-based case–control study
    S. Pouwels
    T. P. van Staa
    A. C. G. Egberts
    H. G. M. Leufkens
    C. Cooper
    F. de Vries
    Osteoporosis International, 2009, 20 : 1499 - 1506
  • [10] Dopaminergic drugs and the risk of hip or femur fracture: a population-based case–control study
    M. E. L. Arbouw
    K. L. L. Movig
    T. P. van Staa
    A. C. G. Egberts
    P. C. Souverein
    F. de Vries
    Osteoporosis International, 2011, 22 : 2197 - 2204